Cristal Therapeutics
  • About us
    • Overview
    • Management team
    • Supervisory board
    • Scientific advisory board
    • Investors
  • Technology
    • CliCr® copper free click chemistry reagent
  • Partnering
  • Media Centre
    • News
  • Contact Us
  • Order now
  • Menu Menu

CliCr® and CliCr® derivatives are available via Iris Biotech GmbH

26th January 2023

As per 25 Jan 2023, Iris Biotech sells CliCr® and CliCr® reagents for non-GXP research purposes. For GXP applications, parties are to connect with Cristal Therapeutics.

Read more information on https://www.iris-biotech.de/de/blog/potm-clicrr-an-innovative-click-reagent/

/wp-content/uploads/2018/11/Cristal_logo_200px.png 0 0 Cristianne Rijcken /wp-content/uploads/2018/11/Cristal_logo_200px.png Cristianne Rijcken2023-01-26 14:48:172023-01-26 14:48:17CliCr® and CliCr® derivatives are available via Iris Biotech GmbH
Connect with us on LinkedIn

Archive

  • 2025
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

© Cristal Therapeutics

Oxfordlaan 55
6229 EV Maastricht
Netherlands

Twitter Cristal Therapeutics
  • Disclaimer

Pages

  • News
  • Overview
  • About us
  • CliCr® copper free click chemistry reagent
  • Management team
  • Supervisory board
  • Scientific advisory board
  • Technology
  • Investors
  • Partnering
  • Media Centre
  • Contact Us
  • Disclaimer

Categories

  • Events
  • News
Scroll to top Scroll to top Scroll to top